down arrow

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000014W7
CNY
61.25
0.13 (0.21%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Why is Jiangsu Hengrui Pharmaceuticals Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 4.19% and Operating profit at 5.55% over the last 5 years
2
The company declared negative results in Mar'25 after positive results in Dec'24
  • INTEREST COVERAGE RATIO(Q) Lowest at 18,276.11
  • INTEREST(Q) Highest at CNY 10.92 MM
3
With ROE of 12.29%, it has a very expensive valuation with a 7.59 Price to Book Value
  • Over the past year, while the stock has generated a return of 23.41%, its profits have risen by 32.1% ; the PEG ratio of the company is 1.9
  • At the current price, the company has a high dividend yield of 0.3
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jiangsu Hengrui Pharmaceuticals Co., Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
23.41%
1.44
31.50%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
4.19%
EBIT Growth (5y)
5.55%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.57
Tax Ratio
12.26%
Dividend Payout Ratio
18.49%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
99,562.58%
ROE (avg)
135,472.87%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
62
Industry P/E
Price to Book Value
7.59
EV to EBIT
53.84
EV to EBITDA
48.08
EV to Capital Employed
17.95
EV to Sales
13.66
PEG Ratio
1.92
Dividend Yield
0.29%
ROCE (Latest)
33.33%
ROE (Latest)
12.29%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
NET SALES(HY)

At CNY 14,855.38 MM has Grown at 27.09%

NET PROFIT(HY)

At CNY 3,521.29 MM has Grown at 59.14%

ROCE(HY)

Highest at 15.4%

RAW MATERIAL COST(Y)

Fallen by -2.94% (YoY

CASH AND EQV(HY)

Highest at CNY 49,285.07 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 1.82%

DEBTORS TURNOVER RATIO(HY)

Highest at 3.81%

-13What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 18,276.11

INTEREST(Q)

Highest at CNY 10.92 MM

Here's what is working for Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Net Sales
At CNY 14,855.38 MM has Grown at 27.09%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Net Profit
At CNY 3,521.29 MM has Grown at 59.14%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv
Highest at CNY 49,285.07 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio
Highest at 1.82%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 3.81%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -2.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Interest
At CNY 10.92 MM has Grown at 386.57%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio
Lowest at 18,276.11
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest
Highest at CNY 10.92 MM
in the last five periods and Increased by 386.57% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."